Alkem Laboratories
ALKEM · Pharma > Pharmaceuticals & Drugs · Chairman: Basudeo N Singh · MD: Sandeep Singh · Listing date: Dec. 23, 2015 · Employees: 15357 · Mumbai · http://www.alkemlabs.com

Stock Price vs Company Growth
1d
1.4%
1w
0.2%
1m
1.9%
3m
5.2%
6m
4.8%
1y
4.7%
5y
14.3%
10y
17.0%
all
15.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 5,452 1.4%
5,085
5,812
Company Overview

Sales
14,712 Cr
Growth: 10.1%
Profit after Tax
2,289 Cr
Growth: -2.9%
Large Cap
65,190 Cr
P/E: 28.3x
Industry P/E: 31.1x
Fundamentals

Sales (Cr) ₹ 14,712
Growth 10.1%
EBITDA 20.4%
P/S 4.4x
Dividend 1.0%
P/E 28.3x
Book Value ₹ 1,156
PEG Ratio 2.8x
ROE 17.0%
P/B 4.7x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
3.97 %
Kishor Kumar Singh
2.86 %
Rajesh Kumar
2.71 %
Rajeev Ranjan
2.54 %
Nawal Kishore Singh
2.5 %
Promoters
Sarandhar Singh* (Please Refer Notes)
21.08 %
Dhananjay Kumar Singh
7.96 %
Basudeo Narain Singh
7.24 %
Mritunjay Kumar Singh
6.38 %
Jayanti Sinha
5.97 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of India’s foremost global pharmaceutical company. The company is engaged in the development, manufacture and marketing of pharmaceuticals with operational footprints across different countries. In India, it has a formidable presence in several therapy segments and consistently features amongst the top ten pharmaceutical companies.
Investors (124)
Followers (20)